Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
M. Delcroix (Leuven, Belgium). New issues in lung transplantation for pulmonary hypertension. Virtual Congress 2020 – Lung transplantation in the era of new drugs

Member's Comments

No comment yet.

Related content which might interest you: Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012 Lung transplantation for pulmonary hypertension: the impact of new drug therapies Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria? Year: 2004 Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Lung transplantation for pulmonary arterial hypertension Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results Year: 2015 Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Source: Eur Respir J 2007; 30: 715-721 Year: 2007 Lung transplantation for pulmonary hypertension Source: Eur Respir Mon 2012; 57: 247-255 Year: 2012 Advanced pulmonary arterial hypertension: mechanical support and lung transplantation Source: Eur Respir Rev, 26 (146) 170089; 10.1183/16000617.0089-2017 Year: 2017 Epoprostenol therapy for primary pulmonary hypertension after rejection of a single donor lung Source: Eur Respir J 2003; 21: 192-194 Year: 2003 Impact of pulmonary hypertension after lung transplantation on functional outcome Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010 Risk stratification in patients with pulmonary arterial hypertension (PAH) and candidates for lung or heart-lung transplantation Source: Virtual Congress 2021 – All about pulmonary arterial hypertension Year: 2021 Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease Source: Eur Respir J 2009; 34: 1348-1356 Year: 2009 Noninfectious pulmonary complications after organ transplantation Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=202 Year: 2005 Lung transplantation for pulmonary fibrosis Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results Year: 2015 Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Outcome of candidates for liver transplantation suffering from portopulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Effects of transplantation on lung and exercise physiology Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=220 Year: 2003 Prognosis in patients with primary pulmonary hypertension awaiting lung transplantion Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 New indications for lung transplantation Source: Annual Congress 2013 –ME12 New indications for lung transplantation Year: 2013 New aspects of pharmacological correction of pulmonary hypertension in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 236s Year: 2002